Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Olson

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Gene Therapy|April 29, 2006
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitroL Vujanovic, E Ranieri, A Gambotto, et al.
Journal of Virology|April 3, 1998
CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolatesM C Gauduin, G P Allaway, W C Olson, et al.
The Journal of Infectious Diseases|March 10, 2001
Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusionK A Nagashima, D A Thompson, S I Rosenfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokinesC C Wilson, W C Olson, T Tuting, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2000
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120E G Cormier, M Persuh, D A Thompson, et al.
Journal of Virology|January 3, 2001
Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140A Trkola, T J Ketas, K A Nagashima, et al.
Nature|November 14, 1996
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5A Trkola, T Dragic, J Arthos, et al.
Journal of Virology|January 7, 2000
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structureJ M Binley, R W Sanders, B Clas, et al.
Journal of Virology|September 1, 1996
Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transferV Litwin, K A Nagashima, A M Ryder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibodyM L Alegre, A M Collins, V L Pulito, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Gene Therapy|April 29, 2006
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitroL Vujanovic, E Ranieri, A Gambotto, et al.
Journal of Virology|April 3, 1998
CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolatesM C Gauduin, G P Allaway, W C Olson, et al.
The Journal of Infectious Diseases|March 10, 2001
Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusionK A Nagashima, D A Thompson, S I Rosenfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokinesC C Wilson, W C Olson, T Tuting, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2000
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120E G Cormier, M Persuh, D A Thompson, et al.
Journal of Virology|January 3, 2001
Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140A Trkola, T J Ketas, K A Nagashima, et al.
Nature|November 14, 1996
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5A Trkola, T Dragic, J Arthos, et al.
Journal of Virology|January 7, 2000
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structureJ M Binley, R W Sanders, B Clas, et al.
Journal of Virology|September 1, 1996
Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transferV Litwin, K A Nagashima, A M Ryder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1992
Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibodyM L Alegre, A M Collins, V L Pulito, et al.
Pageof 3